Cost-Effectiveness of Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation:: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network

BACKGROUND: The Cardiothoracic Surgical Trials Network (CTSN) recently reported no difference in left ventricular end-systolic volume index or in survival at 2-years between patients with severe ischemic mitral regurgitation (MR) randomized to mitral-valve repair or replacement. However, replacement...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Cardiovasc Qual Outcomes
Autors principals: Ferket, Bart S., Ailawadi, Gorav, Gelijns, Annetine C., Acker, Michael A., Hohmann, Samuel F., Chang, Helena L., Bouchard, Denis, Meltzer, David O., Michler, Robert E., Moquete, Ellen G., Voisine, Pierre, Mullen, John C., Lala, Anuradha, Mack, Michael J., Gillinov, A. Marc, Thourani, Vinod H., Miller, Marissa A., Gammie, James S., Parides, Michael K., Bagiella, Emilia, Smith, Robert L., Smith, Peter K., Hung, Judy W., Gupta, Lopa N., Rose, Eric A., O’Gara, Patrick T., Moskowitz, Alan J.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6383805/
https://ncbi.nlm.nih.gov/pubmed/30785252
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars